Clinical Trial Update: Pilot Study to Assess the Safety and Pharmacokinetics of 70-150μm Drug Eluting Beads Loaded With Irinotecan (DEBIRI). [Phase 1]

View source ↗

Summary

This Phase 1 pilot study completed its assessment of safety and pharmacokinetics for irinotecan-loaded drug-eluting beads (DEBIRI) in metastatic colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer Metastatic

Drugs mentioned

• DEBIRI (irinotecan-eluting beads) (irinotecan-eluting beads)

Snippet

Sponsor: Singapore General Hospital | Conditions: Colorectal Cancer Metastatic | Phase 1 | Status: COMPLETED